Skip to main content

Advertisement

Table 1 Baseline demographics, comorbidities, disease severity, clinical and laboratory findings on admission, microbiology, and antibiotic therapy of the study population

From: Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia

  Study population n = 75
Demographics, n. (%)
 Male 43 (57)
 Age, median (IQR) years 75 (59–84)
 Body mass index, median (IQR) 24 (20–27)
 Healthcare-associated pneumonia 5 (7)
Comorbidities, n. (%)
 Active neoplastic disease 12 (16)
 Chronic obstructive pulmonary disease 18 (24)
 Diabetes mellitus 11 (15)
 Cerebrovascular accident 9 (12)
 Liver disease 5 (7)
 Neurological diseases 11 (15)
 Renal disease 8 (11)
 Chronic renal failure 6 (8)
 Family history of coronary artery disease 16 (21)
 Essential arterial hypertension 36 (48)
 Congestive heart failure 7 (9)
 Active coronary artery disease 12 (16)
 Prior acute myocardial infarction 10 (13)
 Atrial fibrillation 2 (3)
 Hyperlipidemia 14 (19)
Medications before admission, n. (%)
 Aspirin 17 (23)
 Beta-blockers 13 (17)
 Angiotensin-converting-enzyme inhibitors 14 (19)
 Antiplatelets 8 (11)
 Statins 12 (16)
Severity on admission, n. (%)
 Mental status change 4 (5)
 PSI Risk Class IV and V 54 (72)
 PSI Risk Class V 21 (28)
 Acute respiratory failure 39 (52)
 Severe sepsis 14 (19)
Clinical and laboratory data on admission, median (IQR)
 Heart rate, bpm 80 (71–92)
 Respiratory rate, bpm 20 (18–25)
 Systolic blood pressure, mmHg 128 (115–146)
 Diastolic blood pressure, mmHg 70 (60–80)
 White blood cells, cell/L−1 11,840 (9180–15,900)
 Hemoglobin, g/dL 12.6 (11–14.2)
 Hematocrit, % 37 (33–41)
 Albumin, g/dL 3.3 (3.1–3.8)
 Platelets, cell/L−1 196,000 (161,000–289,000)
 Lactate dehydrogenase, mg/dL 378 (318–444)
 Blood urea nitrogen, mg/dL 40 (27–49)
 Creatinine, mg/dL 1 (0.8–1.3)
 Sodium, mEq/L 136 (133–139)
 Potassium, mEq/L 4 (3.7–4.4)
 Glucose, mg/dL 119 (106–146)
 C-reactive protein, mg/L 12.9 (6.25–28.8)
 pH 7.46 (7.44–7.48)
Microbiology, n. (%)
 Isolated pathogen 13 (17)
   S. pneumoniae 8 (11)
   S. aureus 2 (3)
   Legionella pneumophila 2 (3)
   P. aeruginosa 1 (1)
Empiric antibiotic treatment, n. (%)
 Ceftriaxone 36 (48)
 Azithromycin 38 (51)
 Levofloxacin 32 (43)
 Ceftazidime 8 (11)
 Piperacillin/tazobactam 9 (12)
 Others 23 (30)
  1. n. number, IQR 25–75 interquartile range, PSI pneumonia severity index